ALGN vs ZBH
Align Technology Inc (ALGN) and Zimmer Biomet Holdings, Inc. (ZBH) are both filed with the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies. ZBH is 1.7× ALGN's size by market cap ($19.0B against $11.3B); ALGN trades at the higher fiscal-year P/E (28.1× against 28.0×); ALGN reports the higher net margin (10.1% against 8.6%); ZBH grew sales faster over three years (+5.9% against +2.7%); and over the past year ALGN returned +11.7% against ZBH's -2.9%.
| ALGN | ZBH | |
|---|---|---|
| Last close | $157.58 | $100.91 |
| Market cap | $11.3B | $19.0B |
| P/E (FY) | 28.1× | 28.0× |
| P/S | 2.8× | 2.3× |
| EV/EBITDA | — | 11.8× |
| Gross margin | 66.7% | — |
| Operating margin | 13.4% | 13.3% |
| Net margin | 10.1% | 8.6% |
| Return on equity | 10.4% | 5.6% |
| Sales growth (3y) | +2.7% | +5.9% |
| EPS growth (3y) | +7.0% | +47.8% |
| Dividend yield | — | 1.0% |
| 1-year return | +11.7% | -2.9% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year — FY2025 (ended 2025-12-31) for both. — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| ALGN | ZBH | |
|---|---|---|
| Institutional holders (13F) | 687 | 908 |
| Insider buyers − sellers (180d) | — | -2 |
| Congressional trades disclosed (180d) | 0 | 1 |
| Executive-branch officials on file — trades disclosed (180d) | 1 | 6 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5. — no open-market Form 4 purchases or sales in the window.
ALGN vs ZBH: common questions
- Is ALGN bigger than ZBH?
- ZBH carries the larger market cap — $19.0B against $11.3B, both struck on 2026-08-27.
- Which trades at a higher P/E, ALGN or ZBH?
- ALGN, at a fiscal-year 28.1× against 28.0× for ZBH. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have ALGN and ZBH performed over the past year?
- ALGN returned +11.7% and ZBH -2.9%, measured on the trailing calendar year to the last close.
- How many institutions hold ALGN and ZBH?
- 687 13F filers report a position in ALGN and 908 in ZBH, on the latest quarter in the panel.
- Are ALGN and ZBH in the same industry?
- Both are filed with the SEC under Orthopedic, Prosthetic & Surgical Appliances & Supplies, which is the classification this pairing is built on.
ALGN overview → · ZBH overview → · ALGN institutional ownership → · ZBH institutional ownership → · Congress and ZBH → · Executive branch and ALGN → · Executive branch and ZBH →
More in Orthopedic, Prosthetic & Surgical Appliances & Supplies: ALGN vs EW · ALGN vs ISRG · ALGN vs STE · EW vs ISRG
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/algn-vs-zbh